No, shock-absorbing garments (MAST/pneumatic antishock trousers) are not used in the management of elevated intracranial pressure (ICP).
Shock garments are contraindicated in modern ICP management and have no role in current neurocritical care protocols. While historical research from 1981 examined pneumatic antishock trousers (MAST) in the context of head injury, this intervention is not part of contemporary ICP management strategies outlined in current guidelines 1, 2.
Current Evidence-Based ICP Management
The management of elevated ICP follows structured, protocol-driven approaches that focus on:
Core Monitoring Strategies
- ICP and cerebral perfusion pressure (CPP) monitoring are fundamental to caring for patients with acute brain injury, particularly those in coma 2
- Both parenchymal ICP monitors and external ventricular drains (EVD) provide reliable data and are the recommended devices 2
- ICP monitoring should be used to guide medical and surgical interventions, with treatment thresholds generally considered to be greater than 20-25 mmHg 2
Decision-Making Framework
The decision to monitor ICP is primarily determined by 1:
- Consciousness examination (Glasgow Coma Scale)
- Suspicion that ICP is elevated
- Concern for neuroworsening without quantitative ICP data
- Value in guiding resuscitation and calculating CPP
- Early warning system for potential deterioration
Modern Management Components 3
- Mechanical ventilation optimization
- Fluid therapy management
- Hemoglobin target adjustment
- Hypertonic saline infusion
- Advanced bedside neuromonitoring
Historical Context on Shock Garments
The 1981 canine study 4 examined MAST devices and found that while ICP did increase with inflation, cerebral perfusion pressure (MAP-ICP) improved in hypovolemic animals. However, this outdated research has no relevance to current ICP management protocols and should not inform modern practice.
Current guidelines make no mention of shock garments as a therapeutic intervention for ICP management, focusing instead on invasive monitoring, medical therapies, and surgical interventions when indicated 1, 2, 3.